Newsroom
Company news, product launches and press coverage from EClinCloud.
Case Studies | Incorporating Patient Experience Data into Clinical Trial Design to Support Drug ApprovalCDE issues guidance on incorporating patient experience data into considerations for key elements of clinical trial design.
Chinese Doctors' Day | Saluting the Guardians of Life!EClinCloud published "Chinese Doctors' Day | Saluting the Guardians of Life!" on 2022-08-19. See this article for the full text and accompanying images.
[Invitation] EClinCloud Invites You to the September 2 Salon on Drug Clinical Trial Development Experience and SkillsFriday, September 2, 13:30 | Floor 1, Building A, Tianhe Incubator Park, Chengdu Hi-Tech Zone
CDE Policy Interpretation | Analysis of the "General Considerations for Organizing Patient Participation in Drug Development (Draft for Comment)"When sponsors organize patient participation in drug development, they can improve the overall quality and success rate of drug development.
EClinCloud Launches Integrated Clinical Trial Cloud Platform to Enable System Interoperability and Improve Clinical Trial Speed and EfficiencyOn July 17, EClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") successfully held the Integrated Clinical Trial Cloud Platform Launch Event themed "Digital Breakthrough: Rising Together with EClinCloud" at the Shangri-La Qiantan, Shanghai. At the event, EClinCloud launched its integrated clinical trial cloud platform and invited senior leaders from clinical medicine, innovative pharmaceutical companies, CROs, capital markets, and other fields to provide comprehensive, multi-dimensional analyses and insights on how to leverage information technology to navigate challenges and overcome bottlenecks in clinical trials.
Keynote Speech by EClinCloud CEO Dr. Qin Long: What Is "Digital Breakthrough" and How to "Rise with the Cloud"?The number of clinical studies worldwide is growing rapidly, with China's growth rate ranking among the highest in the world. The severe current pandemic situation has also created new demands for drug and medical device R&D, such as vaccines capable of countering the continually mutating novel coronavirus and drugs that can improve patient survival and quality of life. However, during the clinical phase of pharmaceutical and medical device R&D, we still face many challenges, such as long development timelines, high costs, and low success rates. In addition, pandemic-related restrictions on travel and medical visits weigh like a heavy boulder on physicians, clinical research professionals, and patients.
Expert Perspectives | The Path to Digital Transformation in Pharmaceutical R&D from Different PerspectivesOn July 17, the EClinCloud Integrated Clinical Trial Cloud Platform launch event was successfully held in Shanghai, featuring an engaging roundtable forum. Moderated by Tom Tang, Senior Vice President at Adlai Nortye, the panel brought together Shen Yifeng, Director of the Clinical Trial Institution Office at Shanghai Mental Health Center; Lyu Cheng, Vice President of Translational Development and Clinical Operations at LianBio; Yu Dongsheng, General Manager of Galaxy Asset Management; and Zhang Hai, Senior Vice President of Clinical Services at Pharmaron Clinical, to analyze the progress, applications, and prospects of digitalizing pharmaceutical R&D from the standpoints of clinical medicine, innovative biopharma, capital markets, and CROs.
Ahead of the Launch Event: A Brief Look at Putting "Patient-Centricity" into Practice in Clinical TrialsEClinCloud CEO Dr. Qin Long will speak at the launch event.
Hi Friend, There's a Launch Event We'd Like to Share With YouTime: July 17, 16:30–20:00 | Venue: Shangri-La Qiantan, Shanghai
EClinCloud Interviewed by VCBeat: Winning Over Investors in Just 30 Minutes, Solving Digital Clinical Trial Pain Points from a Medical Perspective, and Competing with Global IT Giants—How Does This New Entrant Do It?Accelerating timelines, improving efficiency, and reducing costs are the core mission of digital tools. EClinCloud was founded right where industry pain points meet a major industry tailwind.